Nuvigil Labeling Will Likely Include Safety Information From Sparlon Clinical Trials

Cephalon’s follow-on product gets “approvable” letter as FDA considers common labeling for Provigil, Sparlon and Nuvigil.

More from Archive

More from Pink Sheet